MakeMyTrip Ltd vs UiPath Inc — how do they compare? MakeMyTrip Ltd trades at $43.61 (market cap $4.08B), while UiPath Inc trades at $13.26 (market cap $6.81B). The key difference: UiPath Inc is the larger of the two by market cap, and UiPath Inc is trading nearer its 52-week high, MakeMyTrip Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MakeMyTrip Ltd for 12 Days and UiPath Inc for 139 Days on average.
| MMYT | PATH | |
|---|---|---|
Market Cap | $4.08B | $6.81B |
Volume | 1,636,656 | 22,766,109 |
Sector | Consumer Cyclical | Technology |
52-Week High | $94.43 | $19.29 |
52-Week Low | $36.30 | $9.38 |
Typical Hold Time | 12 Days | 139 Days |
Enterprise Value | $4.74B | $5.61B |
Signals from Pluang's Aura AI — not financial advice
MakeMyTrip (MMYT) trades at $43.41 with minimal daily movement (+0.09%). The stock shows mixed technical signals with bearish moving averages but oversold RSI readings. Fundamentally, the company maintains strong revenue growth ($978M in 2025, $1.1B in 2026) but faces margin compression, with net income declining from $95M to $34M. Recent earnings show volatility with two misses and one beat in the last four quarters. Analyst sentiment remains strongly positive with a $77 consensus target representing 77% upside potential.
The investment case hinges on execution amid valuation concerns. While Wall Street maintains bullish ratings (8 Buy, 3 Hold), the high P/E of 188.83 and deteriorating cash flow trends pose risks. The planned Indian subsidiary IPO could unlock value, but investors face headwinds from competitive pressures and inconsistent earnings performance. Current levels offer significant upside to analyst targets if operational improvements materialize.
UiPath (PATH) trades at $13.25, up 1.15% with mixed technical signals showing bearish momentum but neutral oscillators. The company demonstrates improving fundamentals with revenue growing from $1.43B in 2025 to projected $1.7B in 2026, while transitioning from net losses to profitability. Recent partnerships with Snowflake and BDO highlight strategic positioning in AI automation, though the stock faces near-term headwinds from valuation concerns and competitive pressures.
PATH presents a turnaround story with strong revenue growth and path to profitability, but faces execution risks amid competitive automation landscape. The consensus price target of $15.13 suggests 14% upside potential, though technical weakness and mixed analyst sentiment warrant caution. Key catalysts include AI platform adoption and enterprise expansion, while risks involve growth sustainability and margin pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Read more on PATH →